Consortium of Multiple Sclerosis Centers


The CMSC educational programs focus on MS and related disorders in order to facilitate maintenance of professional credentials in your specialty.

CMSC supports a variety of certifications that validate the expertise of multiple disciplines in the specialized are of multiple sclerosis care.

Our Special Interest Groups are organized and engaged communities with a focus on advancing specific disciplines in multiple sclerosis.

We invite our members to participate in our activities and to come forward with ideas. We encourage you to take an active role in our organization by getting involved with one of the many initiatives that may be of interest to you.

CMSC publishes resources to provide our members with the highest quality and most updated information in multiple sclerosis including a peer-reviewed journal and a monthly online newsletter.

The CMSC is committed to optimal services for all those affected by MS. Our Advocacy activities are designed to ensure full access to care, therapies, and research in multiple sclerosis.

Nashville, Tennessee


The Annual Meeting of the CMSC is the largest North American meeting for healthcare professionals and researchers engaged in MS care.

  • Our 2023 meeting had over 1800 attendees and more than 70 exhibitors.
  • We offered over 120 educational hours to meet the needs of our multi-disciplinary learners.


Be part of an engaged community of multiple sclerosis healthcare professionals. Collaborate and share resources with other MS practitioners with the same area of focus.


International Organization of MS Rehabilitation Therapists


Multiple Sclerosis Mental Health Professionals


Multiple Sclerosis PA


Multiple Sclerosis Professionals-in-Training


MS Pharmacists


Multiple Sclerosis Registered Dietitians and Nutritionists

Must Read

Latest Posts

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus.

Press Release: New 48-Week Frexalimab Phase 2 Data Support Potential For High Sustained Efficacy In Multiple Sclerosis
New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis Data support frexalimab as a [...]
The Siegel Rare Neuroimmune Association Marks 30 Years of Improving Quality of Life for People With Rare Neuroimmune Disorders
Not-for-profit celebrates past achievements and looks to the future POWELL, Ohio, February 29, 2024 ( - The Siegel Rare [...]
The Language of MS: How Much Does It Matter?
I got an email recently from someone well up the chain of command at a multiple sclerosis (MS) patient advocacy organization. The purpose [...]
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete [...]
CMSC collaborates with other entities to facilitate our mission and vision.


CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about